Evidence shows that a substantial proportion of patients with COVID-19 experiences long-
term consequences of the disease, but the predisposing factors are poorly understood. We …

Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

Background Passive immunization with plasma collected from convalescent patients has
been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are …

Background: While passive immunotherapy has been considered beneficial for patients with
severe respiratory viral infections, the treatment of COVID-19 cases with convalescent …

Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19 …

Background A large number of studies have been carried out involving passive antibody
administration for the treatment and prophylaxis of COVID-19 and have shown variable …

There is a need for effective therapy for COVID-19 pneumonia. Convalescent plasma has
antiviral activity and early observational studies suggested benefit in reducing COVID-19 …

The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …

Simple Summary Patient-reported outcomes (PROs) are information collected directly from
patients regarding their health status. Emerging evidence has suggested that integrating …

Abstract The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial was set up
in March 2020 to evaluate treatments for people hospitalised with COVID-19. To maximise …